Colchicine Dosing for Gout
Acute Gout Flare Treatment
For treating an acute gout flare in adults with normal renal and hepatic function, administer colchicine 1.2 mg (two tablets) at the first sign of flare, followed by 0.6 mg (one tablet) one hour later, for a total maximum dose of 1.8 mg over one hour. 1, 2
- This low-dose regimen is FDA-approved and provides equivalent efficacy to higher doses while maintaining a safety profile indistinguishable from placebo 1, 3
- The landmark trial demonstrated that 37.8% of patients achieved ≥50% pain reduction at 24 hours with this low-dose regimen versus 15.5% with placebo 3
- Higher doses (4.8 mg over 6 hours) showed no additional benefit but caused significantly more adverse effects, with 76.9% experiencing diarrhea compared to 23% with low-dose colchicine 3
- Do not repeat this treatment course more frequently than every 3 days 2
Critical Timing Consideration
- Early administration at the first sign of flare onset is essential for optimal efficacy 1
- The American College of Rheumatology emphasizes a "medication-in-pocket" strategy for patients who can recognize early flare symptoms 1
Prophylaxis of Gout Flares
For prophylaxis of gout flares in adults with normal renal and hepatic function, prescribe colchicine 0.6 mg once daily or 0.6 mg twice daily (maximum 1.2 mg/day). 1, 2
- Recent evidence demonstrates that 0.5 mg once daily is non-inferior to twice-daily dosing for flare prevention when initiating xanthine oxidase inhibitors, with an incidence rate ratio of 0.93 (95% CI 0.80-1.09) 4
- Once-daily dosing should be preferred as it is associated with better tolerability and lower costs without compromising efficacy 4
- Prophylaxis should be continued for at least 6 months when initiating urate-lowering therapy 1, 2, 5
When Initiating Urate-Lowering Therapy
- Prophylaxis is strongly recommended upon initiation of allopurinol, febuxostat, or pegloticase due to mobilization of urate crystals from tissue deposits 1, 2
- Studies confirm that colchicine prophylaxis (0.5 mg daily for 6 months) significantly reduces both frequency (0.30 vs 2.47 flares, p<0.001) and severity of flares when starting febuxostat 6
Important Caveats and Drug Interactions
Concurrent Prophylaxis and Acute Treatment
- If a flare occurs while on prophylactic colchicine, you may administer the acute treatment dose (1.2 mg followed by 0.6 mg one hour later), then wait 12 hours before resuming the prophylactic dose 2
- However, treatment of acute flares is not recommended in patients taking prophylactic colchicine who are also on strong CYP3A4 or P-glycoprotein inhibitors 2
Critical Drug Interactions
- Colchicine is contraindicated in patients with renal or hepatic impairment who are using potent CYP3A4 inhibitors (clarithromycin, ketoconazole) or P-glycoprotein inhibitors 1, 2
- For patients on moderate CYP3A4 inhibitors without renal/hepatic impairment, dose adjustments are required 2
Common Pitfalls to Avoid
- Never use the outdated high-dose regimen (1.2 mg followed by 0.6 mg hourly for 6 hours) as it provides no additional benefit and causes severe gastrointestinal toxicity 1, 3
- Do not prescribe colchicine as an analgesic for non-gout pain—it has no analgesic properties 2
- Avoid initiating long-term urate-lowering therapy after a first gout attack or in patients with infrequent attacks (<2 per year) 1